Results for chronic disease code Gx - GENERIC (used in compensation list, C1, for another diagnosis)

Chemical substance: pegvisomant

ATC code: H01AX01 • Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Other anterior pituitary lobe hormones and analogues

Chemical substance: miglustat

ATC code: A16AX06 • Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Chemical substance: pegvisomant

ATC code: H01AX01 • Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Other anterior pituitary lobe hormones and analogues

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: imiglucerase

ATC code: A16AB02 • Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: infliximab

ATC code: L04AB02 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: benzathine benzylpenicillin

ATC code: J01CE08 • Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Beta-lactamase sensitive penicillins

Chemical substance: infliximab

ATC code: L04AB02 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Chemical substance: levodopa + carbidopa + entacapone

ATC code: N04BA03 • Nervous system | Dopaminergic agents | Dopa and dopa derivatives

Chemical substance: etanercept

ATC code: L04AB01 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Chemical substance: darbepoetin alfa

ATC code: B03XA02 • Blood and blood forming organs | Other antianemic preparations

Chemical substance: levodopa + carbidopa

ATC code: N04BA02 • Nervous system | Dopaminergic agents | Dopa and dopa derivatives

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: lanreotide

ATC code: H01CB03 • Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues

Chemical substance: adalimumab

ATC code: L04AB04 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Chemical substance: darbepoetin alfa

ATC code: B03XA02 • Blood and blood forming organs | Other antianemic preparations